Valuation: McKesson Corporation

Market Cap 103B 90.3B 85.12B 77.66B 145B 9,854B 146B 1,021B 396B 5,015B 385B 377B 16,320B P/E 2027 *
22.6x
P/E 2028 * 17.9x
Enterprise Value 107B 93.88B 88.5B 80.74B 151B 10,245B 152B 1,062B 412B 5,214B 401B 392B 16,967B EV / Sales 2027 *
0.25x
EV / Sales 2028 * 0.23x
Free-Float
41.53%
Yield 2027 *
0.41%
Yield 2028 * 0.42%
1 day-1.71%
1 week+0.88%
Current month+0.61%
1 month+3.85%
3 months+17.20%
6 months+1.18%
Current year+8.57%
1 week 853
Extreme 853
908.36
1 month 853
Extreme 853
942
Current year 710.01
Extreme 710.01
1,016.97
1 year 710.01
Extreme 710.01
1,016.97
3 years 431.28
Extreme 431.28
1,016.97
5 years 197.26
Extreme 197.255
1,016.97
10 years 108.34
Extreme 108.34
1,016.97
Manager TitleAgeSince
Chief Executive Officer 59 2019-03-31
Chief Tech/Sci/R&D Officer 53 2023-10-02
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 70 2018-04-23
Chairman 59 2026-04-30
Director/Board Member 68 2018-09-11
Change 5-day change 1-year change 3-year change Capi.($)
+0.46%+0.88% - - 103B
-0.04%-0.02%+15.62%+96.99% 103B
+1.71%-0.76%+45.32%+151.80% 51.24B
+0.78%-0.39%-15.41%+263.38% 20.74B
-0.25%-0.87%-10.20%-10.55% 7.96B
-1.66%-0.76%-37.02%-34.93% 6.92B
-0.68%+2.35%-4.34%+12.24% 6.59B
-1.00%-0.80%-18.92%-33.14% 5.99B
+0.12%-0.72%-2.66%+19.97% 4.96B
+7.41%+6.44%+19.50%+21.62% 3.76B
Average +0.48%-0.02%-0.90%+54.15% 23.42B
Weighted average by Cap. -0.22%-1.47%+15.11%+108.78%

Financials

2027 *2028 *
Net sales 432B 380B 358B 327B 611B 41,454B 616B 4,297B 1,665B 21,098B 1,621B 1,586B 68,655B 462B 407B 383B 350B 654B 44,388B 659B 4,601B 1,783B 22,591B 1,736B 1,698B 73,514B
Net income 4.69B 4.13B 3.89B 3.55B 6.64B 450B 6.69B 46.67B 18.09B 229B 17.61B 17.23B 746B 5.62B 4.94B 4.66B 4.25B 7.95B 540B 8.01B 55.93B 21.67B 275B 21.1B 20.64B 894B
Net Debt 4.07B 3.58B 3.37B 3.08B 5.76B 391B 5.8B 40.5B 15.69B 199B 15.28B 14.95B 647B 3.19B 2.8B 2.64B 2.41B 4.51B 306B 4.55B 31.72B 12.29B 156B 11.97B 11.71B 507B
Logo McKesson Corporation
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows: - distribution of pharmaceutical products (91.3%); - distribution of medical and surgical products (3.1%); - other (1.5%): primarily technology services and software sales. The remaining net sales (4.1%) are from international activities.
Employees
42,300
Date Price Change Volume
26-09-23 US$889.47 -0.27% 53
26-09-22 US$891.88 -0.05% 133
26-09-21 US$892.31 +1.46% 395
26-09-18 US$879.48 -0.07% 236
26-09-17 US$880.11 -0.87% 139
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
880.50USD
Average target price
980.73USD
Spread / Average Target
+11.38%

Quarterly revenue - Rate of surprise